Registration Document - Pernod Ricard
Registration Document - Pernod Ricard
Registration Document - Pernod Ricard
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ABOUT THE COMPANY AND ITS SHARE CAPITAL 7<br />
Information about share capital<br />
Information about share capital<br />
The conditions under which the bylaws submit changes to the share<br />
capital and the rights attached thereto are compliant in every aspect<br />
with legal stipulations in France. The bylaws do not provide for any<br />
overriding provisions and do not impose any special contingencies.<br />
Amount of paid-up capital<br />
at 30 June 2009<br />
On 7 April 2009, the Board of Directors recorded that on 1 April 2009<br />
the share capital had increased by a nominal amount of €163,693.95<br />
as a result of the exercise of 105,609 stock options, since 1 July 2008,<br />
granting entitlement to the same number of <strong>Pernod</strong> <strong>Ricard</strong> shares.<br />
On 14 May 2009, the Company recorded a cash capital increase<br />
through which 38,786,220 new shares were issued, leading to a capital<br />
increase for the Company for the nominal amount of €60,118,641.<br />
On 22 July 2009, the Board of Directors recorded that on 30 June 2009<br />
the share capital had increased by a nominal amount of €101,886.15<br />
as a result of the exercise of 65,733 stock options, since 14 May 2009,<br />
granting entitlement to the same number of <strong>Pernod</strong> <strong>Ricard</strong> shares.<br />
As a result, <strong>Pernod</strong> <strong>Ricard</strong>’s subscribed and fully paid up share capital<br />
amounted to €400,892,830.80 as of 30 June 2009, divided into<br />
258,640,536 shares with a nominal value of €1.55.<br />
Shares not representing<br />
capital<br />
There are no shares that do not represent the Company’s share<br />
capital.<br />
<strong>Pernod</strong> <strong>Ricard</strong> shares held by Le Delos Invest I, Le Delos Invest II and<br />
Lirix (companies controlled by Société Paul <strong>Ricard</strong> SA, as defined in<br />
article 233-3 of the French Commercial Code) are pledged for third<br />
parties.<br />
<strong>Pernod</strong> <strong>Ricard</strong> shares held by Le Delos Invest III (a company<br />
controlled by Société Paul <strong>Ricard</strong> SA, as defined in article 233-3 of the<br />
French Commercial Code) were transferred as collateral for the good<br />
performance of its obligations under the terms of a prepaid forward<br />
transaction entered into on 10 April 2009.<br />
Financial authorisations<br />
General authorisations<br />
The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />
of 7 November 2007 granted the Board of Directors a number of<br />
financial authorisations, for a period of 26 months, in accordance<br />
with article L. 225-129 et seq. of the French Commercial Code, of which<br />
the main terms are outlined below. The purpose of the authorisations<br />
are to allow the Company, if necessary, to increase in due course their<br />
capital either by the capitalisation of reserves, earnings, premiums or<br />
others, or the issue, with or without preferential subscription rights,<br />
of different securities granting access, immediately or in the future,<br />
to <strong>Pernod</strong> <strong>Ricard</strong>’s capital.<br />
The same Meeting also delegated authority to the Board of Directors<br />
to decide, if the expected demand is exceeded at the time of a capital<br />
increase with or without preferential subscription rights, to increase<br />
the shares issued at the same price as that in the initial issue, within<br />
the regulatory periods and limits.<br />
Since the majority of these authorisations expire in January 2010,<br />
at the Shareholders’ Meeting of 2 November 2009 a number of new<br />
financial authorisations will be put to the vote, of which the terms<br />
and conditions are outlined under “Presentation of the resolutions”<br />
in the section “Combined (Ordinary and Extraordinary) Shareholders’<br />
Meeting” in this document.<br />
Securities representing capital<br />
(i) Issues of shares or securities with preferential<br />
subscription rights<br />
The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />
of 7 November 2007 authorised the Board of Directors to:<br />
◆ perform one or more capital increases, via the issue of ordinary<br />
shares and/or securities granting access to the share capital, with<br />
preferential subscription rights;<br />
◆ perform one or more capital increases, via the capitalisation of<br />
premiums, reserves, earnings or others.<br />
The maximum nominal amount of capital increases that may be<br />
performed under the aforementioned authorisations was set at<br />
€170 million: this is an overall limit applied to all issues performed<br />
under any of the aforementioned authorisations, as well as any<br />
issue performed with cancellation of preferential rights (it being<br />
specified that the maximum nominal amount of the latter is limited<br />
to €68 million).<br />
If necessary, a supplementary amount will be added to this limit for<br />
shares to be issued, in accordance with the law, to preserve the rights<br />
of holders of securities or rights granting access to share capital.<br />
The maximum nominal amount of debt securities that may be issued<br />
within the scope of the first authorisation, mentioned above, was set<br />
at €5 billion.<br />
(ii) Issues of shares or securities with cancellation<br />
of preferential subscription rights<br />
The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />
of 7 November 2007 authorised the Board of Directors to:<br />
◆ carry out one or more capital increases, via the issue of ordinary<br />
shares or securities granting access to share capital with<br />
cancellation of preferential subscription rights, via public offer,<br />
within the limits of a maximum nominal amount of €68 million<br />
(the Board of Directors is bound by legal and regulatory constraints<br />
in terms of the issue price). This amount will be deducted from the<br />
I REFERENCE DOCUMENT 2008/2009 I PERNOD RICARD 185